Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future “Knock-Out Trials” in Heart Failure

By sjmartinez • October 20, 2024

Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future "Knock-Out Trials" in Heart Failure. Am J Med. 2024 Oct 16:S0002-9343(24)00638-7. doi: 10.1016/j.amjmed.2024.10.015. Epub ahead of print. PMID: 39424217.

Tags: beta-blockers, Cardiology/Epi, digoxin, discontinuation, heart failure, HFrEF, Publications

Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension

McLaughlin VV, Howard L, Elwing J, Fernandes CC, Gaine S, Galiè N, Oudiz RJ, Stefani M, Stickel S, Strachan P, Tamura Y, Kim NH. Evaluating[...]

Decontrasted Image Registration Improves Quantification of Extracellular Volume and Fractional Myocardial Blood Volume

Lu M, Mahmoudi M, Nguyen KL, Xie Y. Decontrasted Image Registration Improves Quantification of Extracellular Volume and Fractional Myocardial Blood Volume. NMR Biomed. 2025 Dec;38(12):e70179.[...]

Author Correction: Kilohertz volumetric imaging of in vivo dynamics using squeezed light field microscopy

Wang Z, Zhao R, Wagenaar DA, Espino D, Sheintuch L, Benshlomo O, Kang W, Zhu E, Lee CK, Schmidt WC, Pammar A, Wang J, Wong[...]